3-iodobenzylguanidine has been researched along with Adrenocortical Hyperfunction in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ansari, AN; DeQuattro, V; Gazarian, LH; Siegel, ME | 1 |
Besser, GM; Bomanji, J; Britton, KE; Fettich, J; Flatman, WD; Horne, T; Ross, G | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and Adrenocortical Hyperfunction
Article | Year |
---|---|
Imaging of medullary thyroid carcinoma and hyperfunctioning adrenal medulla using iodine-131 metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocortical Hyperfunction; Adult; Carcinoma; Female; Humans; Hyperplasia; Iodobenzenes; Multiple Endocrine Neoplasia; Pheochromocytoma; Radionuclide Imaging; Thyroid Neoplasms | 1986 |
Quantitation of iodine-123 MIBG uptake by normal adrenal medulla in hypertensive patients.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenal Medulla; Adrenocortical Hyperfunction; Adult; Diagnosis, Differential; Humans; Hypertension; Image Enhancement; Iodine Radioisotopes; Iodobenzenes; Models, Structural; Pheochromocytoma; Radionuclide Imaging | 1987 |